aTyr Pharma(LIFE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LIFE aTyr Pharma

盘前交易 07-22 08:23:07 EDT

1.90

+0.00

0.00%

最高1.90	最低1.90	成交量0.00
今开1.90	昨收1.90	日振幅0.00%
总市值1.31亿	流通市值1.28亿	总股本6,901万
成交额50.68万	换手率0.00%	流通股本6,717万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LIFE","market":"US","secType":"STK","nameCN":"aTyr Pharma","latestPrice":1.9,"timestamp":1717531200000,"preClose":1.9,"halted":8,"volume":0,"delay":0,"floatShares":67173358,"shares":69010940,"eps":-0.904057,"marketStatus":"盘前交易","marketStatusCode":1,"change":0,"latestTime":"07-22 08:23:07 EDT","open":1.9,"high":1.9,"low":1.9,"amount":506804.019567,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.904057,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"symbolChange":{"newSymbol":"ATYR","executeDate":"2024-06-05"},"adr":0,"listingDate":1430971200000,"adjPreClose":1.9,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/LIFE/wiki","defaultTab":"wiki","newsList":[{"id":"2439869503","title":"Atyr Pharma, Inc.盘中异动 快速下跌5.03%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439869503","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439869503?lang=zh_cn&edition=full","pubTime":"2024-05-30 01:01","pubTimestamp":1717002103,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日01时01分，Atyr Pharma, Inc.股票出现异动，股价大幅下挫5.03%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。该信息摘要如下：AtyR Pharma Inc：Jonestrading假设承保范围为买入评级；目标价为22美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530010144968108ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530010144968108ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","LIFE"],"gpt_icon":0},{"id":"2439528379","title":"AtyR Pharma Inc：Jonestrading假设承保范围为买入评级；目标价为22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439528379","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439528379?lang=zh_cn&edition=full","pubTime":"2024-05-29 19:36","pubTimestamp":1716982576,"startTime":"0","endTime":"0","summary":"AtyR Pharma Inc：Jonestrading假设承保范围为买入评级；目标价为22美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405291936199574b304&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405291936199574b304&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIFE"],"gpt_icon":0},{"id":"2438098768","title":"AtyR Pharma根据纳斯达克上市规则5635 (C) (4) 宣布激励补助金","url":"https://stock-news.laohu8.com/highlight/detail?id=2438098768","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438098768?lang=zh_cn&edition=full","pubTime":"2024-05-25 04:05","pubTimestamp":1716581123,"startTime":"0","endTime":"0","summary":"AtyR Pharma根据纳斯达克上市规则5635 (C) (4) 宣布激励补助金","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525040526955ab804&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525040526955ab804&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTL","LU1162221912.USD","LU0310800965.SGD","LU0648001328.SGD","BK4007","LIFE","QQQ","MNQmain","LU0052756011.USD","BK4566","BK4585","LU0128525689.USD","BK4588","TQQQ","QID","BK4207","BK4504","NDX","BK4534","QLD","BK4563","LU0098860793.USD","PSQ","LU0980610538.SGD","LU0320765646.SGD","BK4139","IE00BSNM7G36.USD","LU0130102774.USD","LU1267930227.SGD","SQQQ","NQmain","LU1201861249.SGD",".IXIC"],"gpt_icon":0},{"id":"2435541320","title":"Atyr Pharma, Inc.盘中异动 下午盘大幅上涨5.00%报1.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435541320","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435541320?lang=zh_cn&edition=full","pubTime":"2024-05-15 01:37","pubTimestamp":1715708252,"startTime":"0","endTime":"0","summary":"北京时间2024年05月15日01时37分，Atyr Pharma, Inc.股票出现异动，股价大幅上涨5.00%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Humacyte Inc C/Wts 27/08/2026 、Prokidney Corp.涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为159.87%、60.37%、33.58%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为69.43%、65.81%、53.25%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150137337927a2d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150137337927a2d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIFE","BK4563"],"gpt_icon":0},{"id":"2433820836","title":"aTyr Pharma Inc 公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433820836","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433820836?lang=zh_cn&edition=full","pubTime":"2024-05-07 20:00","pubTimestamp":1715083246,"startTime":"0","endTime":"0","summary":"   * aTyr Pharma Inc   报告，截至3月底的季度调整后每股亏损23美分，高于去年同期的每股-29美分。五位分析师对该季度的平均预期是每股亏损 24 美分。* 营业收入为 235.00 万美元，分析师预期为 20.00 万美元。* aTyr Pharma Inc 公布的本季度每股收益为亏损 23 美分。* 该公司当季亏损 1549 万美元。* aTyr Pharma Inc 本季度股价下跌了 14.9%，今年迄今为止上涨了 17.7%。5月7日 - 预测变化   * 过去三个月，分析师的平均盈利预期下降了约 12.4%。华尔街对 aTyr Pharma Inc 的 12 个月目标价中位数为 20.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","LIFE"],"gpt_icon":0},{"id":"2433288650","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.90%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433288650","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433288650?lang=zh_cn&edition=full","pubTime":"2024-05-07 01:18","pubTimestamp":1715015919,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日01时18分，Atyr Pharma, Inc.股票出现异动，股价大幅上涨5.90%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。该信息摘要如下：HC Wainwright & Co.：重申aTyr Pharma评级，由买入调整至买入评级, 目标价35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050701184087e85dfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050701184087e85dfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIFE","BK4563"],"gpt_icon":0},{"id":"2432139080","title":"HC Wainwright & Co.：重申aTyr Pharma(LIFE.US)评级，由买入调整至买入评级, 目标价35.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432139080","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432139080?lang=zh_cn&edition=full","pubTime":"2024-05-04 04:05","pubTimestamp":1714766701,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申aTyr Pharma(LIFE.US)评级，由买入调整至买入评级, 目标价35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040405048b714564&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040405048b714564&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIFE"],"gpt_icon":0},{"id":"2432975238","title":"aTyr Pharma Inc   预计每股亏损24美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432975238","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432975238?lang=zh_cn&edition=full","pubTime":"2024-05-03 20:00","pubTimestamp":1714737612,"startTime":"0","endTime":"0","summary":"   * aTyr Pharma Inc    在公布截至2024年6月30日的财报时，预计季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于加利福尼亚州圣地亚哥的公司预计将实现2万美元的营收。* LSEG 分析师对 aTyr Pharma Inc 的平均预期是每股亏损 24 美分。* 在过去三个月中，分析师的平均盈利预期下降了约 12.4%。* 华尔街对 aTyr Pharma Inc 的 12 个月目标价中位数为 20.00 美元，高于其最新收盘价 1.60 美元。5月3日 - 以前的季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIFE"],"gpt_icon":0},{"id":"2429176976","title":"Atyr Pharma, Inc.盘中异动 急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429176976","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429176976?lang=zh_cn&edition=full","pubTime":"2024-04-23 00:07","pubTimestamp":1713802058,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日00时07分，Atyr Pharma, Inc.股票出现波动，股价快速拉升5.00%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.31%。其相关个股中，Moolec Science Sa C/Wts 、Moolec Science Sa、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Moolec Science Sa、Nkgen Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为186.68%、81.68%、59.04%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、Nkgen Biotech, Inc.，振幅分别为247.52%、82.14%、36.17%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230007397a549cdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230007397a549cdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","LIFE","BK4139"],"gpt_icon":0},{"id":"2428780222","title":"Atyr Pharma, Inc.盘中异动 大幅跳水5.00%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428780222","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428780222?lang=zh_cn&edition=full","pubTime":"2024-04-17 03:58","pubTimestamp":1713297534,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日03时58分，Atyr Pharma, Inc.股票出现波动，股价快速下挫5.00%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Jaguar Health, Inc.、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Longeveron Inc.、Jaguar Health, Inc.较为活跃，换手率分别为3380.26%、293.99%、216.25%，振幅较大的相关个股有Palisade Bio, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.，振幅分别为103.61%、101.94%、97.81%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170358547a533324&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170358547a533324&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","LIFE","BK4139"],"gpt_icon":0},{"id":"2427688001","title":"Atyr Pharma, Inc.盘中异动 下午盘快速跳水5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427688001","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427688001?lang=zh_cn&edition=full","pubTime":"2024-04-16 02:53","pubTimestamp":1713207188,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日02时53分，Atyr Pharma, Inc.股票出现波动，股价快速下挫5.14%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、安皮奥制药、Longeveron Inc.涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1561.98%、1240.56%、875.69%，振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为273.33%、117.12%、80.04%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160253097a52e136&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160253097a52e136&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","LGVN","LIFE","BK4139"],"gpt_icon":0},{"id":"2426112399","title":"Atyr Pharma, Inc.盘中异动 临近收盘股价大跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426112399","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426112399?lang=zh_cn&edition=full","pubTime":"2024-04-10 03:57","pubTimestamp":1712692626,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日03时57分，Atyr Pharma, Inc.股票出现波动，股价急速跳水5.46%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Biocardia Inc C/Wts 06/08/2024、Calidi Biotherapeutics, Inc.、Acrivon Therapeutics, Inc.涨幅较大，Mymd Pharmaceuticals, Inc.、Allarity Therapeutics, Inc.、Acrivon Therapeutics, Inc.较为活跃，换手率分别为498.14%、181.03%、168.29%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Nutriband Inc C/Wts 、Vbi Vaccines, Inc.，振幅分别为118.42%、87.27%、72.75%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410035706861e44af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410035706861e44af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","LIFE"],"gpt_icon":0},{"id":"2424043276","title":"Atyr Pharma, Inc.盘中异动 股价大跌5.22%报1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424043276","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424043276?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:36","pubTimestamp":1712065014,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时36分，Atyr Pharma, Inc.股票出现波动，股价大幅下跌5.22%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.43%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Avalo Therapeutics, Inc.、Imunon, Inc.、Vbi Vaccines, Inc.较为活跃，换手率分别为11.47%、10.85%、10.16%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Trevena, Inc.、Gri Bio, Inc.，振幅分别为48.62%、24.98%、18.66%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402213655861e2fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402213655861e2fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIFE","BK4563"],"gpt_icon":0},{"id":"2422910625","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422910625","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422910625?lang=zh_cn&edition=full","pubTime":"2024-03-28 00:09","pubTimestamp":1711555793,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日00时09分，Atyr Pharma, Inc.股票出现异动，股价急速拉升5.74%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Ibio, Inc.、Moolec Science Sa C/Wts 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为3189.54%、1194.36%、70.69%，振幅较大的相关个股有Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Stoke Therapeutics, Inc.，振幅分别为86.96%、78.00%、58.70%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328000953791d510d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328000953791d510d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","LIFE","BK4139"],"gpt_icon":0},{"id":"2421464410","title":"Atyr Pharma, Inc.盘中异动 早盘股价大跌5.35%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421464410","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421464410?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:40","pubTimestamp":1711028407,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时40分，Atyr Pharma, Inc.股票出现异动，股价大幅下挫5.35%。截至发稿，该股报1.91美元/股，成交量4.2483万股，换手率0.06%，振幅2.72%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321214007861e0195&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321214007861e0195&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIFE","BK4563"],"gpt_icon":0},{"id":"2419026979","title":"Atyr Pharma, Inc.2023财年实现净利润-50.39百万美元，同比减少11.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419026979","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419026979?lang=zh_cn&edition=full","pubTime":"2024-03-16 00:22","pubTimestamp":1710519748,"startTime":"0","endTime":"0","summary":"12月31日，Atyr Pharma, Inc.公布财报，公告显示公司2023财年净利润为-50.39百万美元，同比减少11.14%；其中营业收入为353000.00美元，同比减少96.60%，每股基本收益为-0.94美元。从资产负债表来看，Atyr Pharma, Inc.总负债30.18百万美元，其中短期债务1.33百万美元，资产负债比为0.05，流动比率为0.07。机构评级：截至2023年12月31日，当前有5家机构对Atyr Pharma, Inc.目标价做出预测，其中目标均价为22.60美元，其中最低目标价为12.00美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403160022398b383fdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403160022398b383fdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIFE"],"gpt_icon":0},{"id":"2419871974","title":"Atyr Pharma, Inc.盘中异动 早盘股价大涨6.79%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419871974","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419871974?lang=zh_cn&edition=full","pubTime":"2024-03-15 21:35","pubTimestamp":1710509732,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日21时35分，Atyr Pharma, Inc.股票出现波动，股价急速上涨6.79%。截至发稿，该股报1.73美元/股，成交量8.5593万股，换手率0.15%，振幅4.94%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031521353287e7957a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031521353287e7957a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIFE","BK4563","BK4139"],"gpt_icon":0},{"id":"2419795392","title":"aTyr Pharma Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2419795392","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419795392?lang=zh_cn&edition=full","pubTime":"2024-03-15 05:01","pubTimestamp":1710450107,"startTime":"0","endTime":"0","summary":"   * aTyr Pharma Inc   报告，截至12月底的季度调整后每股亏损25美分，高于去年同期的每股-26美分。五位分析师对该季度的平均预期是每股亏损 24 美分。华尔街预期为每股亏损 28 美分至 21 美分。* aTyr Pharma Inc 公布的本季度每股收益为亏损 25 美分。* 该公司当季亏损 1476 万美元。* 本季度，aTyr Pharma Inc 的股价上涨了 15.6%。华尔街对 aTyr Pharma Inc 的 12 个月目标价中位数为 25.00 美元。本摘要由 LSEG 3 月 14 日 09:00 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIFE","BK4139","BK4563"],"gpt_icon":0},{"id":"2419155599","title":"aTyr Pharma Inc   预计每股亏损24美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2419155599","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419155599?lang=zh_cn&edition=full","pubTime":"2024-03-13 05:35","pubTimestamp":1710279313,"startTime":"0","endTime":"0","summary":"   * aTyr Pharma Inc    将于3月14日公布截至2023年12月31日的季度财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于加利福尼亚州圣地亚哥的公司的营收预计将从去年同期的1039万美元下降99.5%至5.2万美元。* LSEG 分析师对 aTyr Pharma Inc 的平均预期是每股亏损 24 美分。* 华尔街对 aTyr Pharma Inc 的 12 个月目标价中位数为 25.00 美元，高于其上一次收盘价 1.60 美元。3月12日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIFE"],"gpt_icon":0},{"id":"2417726443","title":"Atyr Pharma, Inc.盘中异动 快速下挫8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417726443","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417726443?lang=zh_cn&edition=full","pubTime":"2024-03-05 23:37","pubTimestamp":1709653035,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日23时37分，Atyr Pharma, Inc.股票出现异动，股价急速下跌8.38%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.62%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 、Apogee Therapeutics, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为253.21%、129.42%、71.36%，振幅较大的相关个股有Ys Biopharma Co Ltd C/Wts 15/03/2028 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为70.24%、68.86%、51.22%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403052337167a49bc8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403052337167a49bc8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIFE","BK4139","OCEA","BK4563"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atyrpharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.1875},{"period":"6month","weight":0.2667},{"period":"1year","weight":-0.064},{"period":"ytd","weight":0.3475}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"aTyr Pharma, Inc.于2005年9月8日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，利用进化智能将tRNA合成酶生物学转化为纤维化和炎症的新疗法。tRNA合成酶是古老的、必需的蛋白质，它们已经进化出新的结构域，在人类的胞外调节不同的途径。该公司的发现平台专注于通过发现由所有20种tRNA合成酶衍生的结构域专有库驱动的信号通路来解锁隐藏的治疗干预点。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.022427},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.026924},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.036889},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.052458},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.096577},{"month":6,"riseRate":0.6,"avgChangeRate":-0.014529},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.024172},{"month":8,"riseRate":0.111111,"avgChangeRate":-0.082422},{"month":9,"riseRate":0.555556,"avgChangeRate":0.120154},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.07207},{"month":11,"riseRate":0.555556,"avgChangeRate":0.026072},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.077972}],"exchange":"NASDAQ","name":"aTyr Pharma","nameEN":"aTyr Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"aTyr Pharma(LIFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供aTyr Pharma(LIFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"aTyr Pharma,LIFE,aTyr Pharma股票,aTyr Pharma股票老虎,aTyr Pharma股票老虎国际,aTyr Pharma行情,aTyr Pharma股票行情,aTyr Pharma股价,aTyr Pharma股市,aTyr Pharma股票价格,aTyr Pharma股票交易,aTyr Pharma股票购买,aTyr Pharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"aTyr Pharma(LIFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供aTyr Pharma(LIFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}